Osteoporosis
Study finds higher-dose ibandronate regimen effective and safe
Published in Women's Health Weekly, July 22nd, 2004
According to a study from Italy, "Oral bisphosphonates are established therapeutics for postmenopausal osteoporosis. Alternative, simplified dosing regimens that improve tolerability and promote convenience may be advantageous.
"Ibandronate is a highly potent, nitrogen-containing bisphosphonate that can be administered as a convenient intravenous (iv) injection (over 15-30 seconds) in schedules featuring extended between-dose intervals," reported S. Adami and colleagues in a recent issue of the journal Bone (Efficacy...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Assisted Reproduction
E.U. enlargement could lead to 'fertility tourism' from West to East - Disease Associations
In young women, depression doubles risk of metabolic syndrome - Gynecologic Surgery
Surgical procedure prevents genital prolapse following Burch colposuspension - Immunology
Inflammation due to CD40 activation in early pregnancy causes fetal resorption - Ovarian Cancer
Lysophospholipid levels are potential disease indicator - Alzheimer Disease
Genistein may be an alternative to estrogen for treatment of AD - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
